Business

Industrial Realty Group has met with Philadelphia Industrial Development Corp. and the local Steelworkers union to discuss the South Philly complex.

Attorneys for some 2,000 local governments say they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation's opioid crisis.

The head of Pennsylvania’s Manufacturer’s Association said he supports the president’s trade tactics.

Neighborhood groups across the Northeast are on a campaign to shut down hookah bars they see as disruptive to their community.

"The Sacklers refused to budge," the email concluded, "and have declined to offer any counterproposal."

We discuss Walmart's decision to stop selling handguns and certain types of ammunition. And we look at what gun laws and measures are effective at reducing gun violence.

We look at the rising popularity of meat alternatives -- burgers, sausages, and nuggets-- that are turning up at grocery stores and fast food chains.

The Viticulture Trail Sign Program will be an effort to boost the profile of the state’s wine industry by constructing more road signs that point motorists to nearby vineyards

The Pennsylvania Gaming Control Board will hold at least one more auction for a mini-casino license.

Born on the water in Philadelphia, the Slinky was developed by one of the first great women of the American toy industry.

The formulas would take into account the number of people in a given jurisdiction who misuse opioids, the number of overdose deaths and other factors.

Waste Management wants state approval to increase landfill’s height from 130 to 190 feet. But New Castle County intervenes with new law that caps height at 140 feet.

Philip Rinaldi announced a new company, Philadelphia Energy Industries, and a plan to buy and restart the Point Breeze and Girard Point refineries.

Under the settlement, the Sackler family would give up ownership of the company and Purdue Pharma would supply its addiction treatment drugs free to the public.

An Oklahoma judge found Johnson & Johnson and its subsidiaries helped fuel the opioid crisis and ordered the consumer products giant to pay $572M to clean up the problem.